Literature DB >> 9355782

Drug therapy for ulcerative colitis during pregnancy.

R Modigliani1.   

Abstract

Women with ulcerative colitis (UC) are usually young and thus likely to undergo pregnancy. They should be advised to conceive when the disease is quiescent. Steroids and salicylates may be used normally during pregnancy, possibly without exceeding a dose of 2g/day for mesalazine. Azathioprine can be maintained if its indication is clear cut. Cyclosporin seems to be without additional risk in the pregnant woman, its use being limited to acute steroid-refractory disease, as an alternative to surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355782     DOI: 10.1097/00042737-199709000-00006

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Delivery of a normal newborn after intensive medical treatment for an acute exacerbation of ulcerative colitis during pregnancy: a case report.

Authors:  N Ishijima; E Ojima; H Tonouchi; H Suzuki; S Fukunishi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Authors:  W Connell; A Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 3.  Ciclosporin use during pregnancy.

Authors:  Karolina Paziana; Magaly Del Monaco; Elyce Cardonick; Michael Moritz; Matthew Keller; Bruce Smith; Lisa Coscia; Vincent Armenti
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

Review 4.  Pregnancy and medications in inflammatory bowel disease.

Authors:  Rena H Cao; Michael C Grimm
Journal:  Obstet Med       Date:  2020-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.